Chilblain lesions after COVID-19 mRNA vaccine.

Pileri, A; Guglielmo, A; Raone, B; Patrizi, A

Pileri, A; Guglielmo, A; Raone, B; Patrizi, A.

Pileri A; Dermatology-IRCCS Policlinico di Sant'Orsola, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Italy.
Guglielmo A; Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
Raone B; Dermatology-IRCCS Policlinico di Sant'Orsola, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum, University of Bologna, Italy.
Patrizi A; Dermatology Unit, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.

Br J Dermatol ; 185(1): e3, 2021 07.

Article in English | MEDLINE | ID: covidwho-1201188

Subject(s)

COVID-19; Chilblains; COVID-19 Vaccines; Chilblains/etiology; Humans; RNA, Messenger; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chilblains / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Br J Dermatol Year: 2021 Document Type: Article Affiliation country: Bjd.20060

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google